Dabur is now going to invest Rs. 550 crore for a new manufacturing facility in Madhya Pradesh, which it said would be one of its largest plants in the world. The new plant would be manufacturing foods, ayurvedic medicines, and health supplements and would provide direct and indirect employment to 1,250 people in the first phase and over 3,000 people subsequently.
We have a clear growth strategy; this facility will provide us space to rapidly expand production capacity for ayurvedic products and medicines, as well as innovative foods,” Dabur chief executive officer Mohit Malhotra said.Since the Covid outbreak, demand for ayurvedic products has seen rapid growth. Products like Chyawanprash, honey, and health juices have been witnessing record growth across channels including e-commerce.